Company intelligence / Profile preview

Zhi Zhi Medicine

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Zhizhi Medicine is a China-based biotechnology company focused on the discovery and development of innovative small molecule therapeutics. The company leverages advanced structure-based drug design (SBDD) and medicinal chemistry platforms to target challenging biological pathways in oncology and immunology. Zhizhi Medicine aims to address significant unmet medical needs by developing highly selective and potent drug candidates. Currently, the company's pipeline is in the early stages of development, with a focus on transitioning lead programs into clinical trials.

Therapeutic areas: OncologyImmunology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Zhi Zhi Medicine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhi Zhi Medicine.

Explore the full profile